Company Overview of Aeras
Aeras is a non-profit organization working through public-private partnerships to develop new vaccines against tuberculosis.
1405 Research Boulevard
Rockville, MD 20850
Founded in 1997
Key Executives for Aeras
Compensation as of Fiscal Year 2015.
Aeras Key Developments
Aeras Welcomes David Blumberg to its Board of Directors
Jul 20 15
David L. Blumberg recently joined Aeras's Board of Directors. He has more than 20 years of business and consulting experience across the life sciences continuum, including global, specialty, and generic pharmaceuticals, biotech, and medical devices and products. Mr. Blumberg recently retired from KPMG where he led their U.S. Pharmaceuticals and Life Sciences Advisory practice.
Aeras Announces Executive Changes
Jul 15 15
Aeras announced a new leadership structure for the nonprofit biotech organization with Jacqueline E. Shea, Ph.D., the current Chief Operating Officer (COO), assuming the role of Chief Executive Officer (CEO), effective August 12. Thomas G. Evans, M.D., will step down as CEO to become Acting Chief Scientific Officer (CSO). Ann M. Ginsberg, M.D., Ph.D., will continue as Chief Medical Officer.
Dara Erck Joins Aeras as Vice President of External Affairs
Jun 15 15
Aeras announced that Dara Erck joins the organization as the Vice President of External Affairs. As a member of the senior leadership team, Ms. Erck will be responsible for resource mobilization, advocacy, and communications. Ms. Erck has more than 15 years' experience in the global health field. She previously was the managing director of Erck Consulting, where she provided long-term consulting services for the Bill & Melinda Gates Foundation, The Flowers Foundation, and other clients in the global health arena.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries